MILPITAS Calif. March 7 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today reported its financial results for the fourth quarter and full year ended December 31 2016 and provided an update on the company's recent achievements."In 2016 Pr...
↧